bilingoz - English Learning for Pharmaceutical and Health Professionals

AR: FDA is warning the public about a potentially dangerous counterfeit version of the weight-loss drug Alli (orlistat). To date, all the counterfeits seem to have been sold on the internet. The genuine version of Alli, which is approved by FDA for over-the-counter use, contains a substance that prevents the absorption of fats from the diet. The counterfeit Alli contains the stimulant drug sibutramine, which can cause potentially fatal side effects, particularly in people with a history of heart disease.
MB: Sibutramine is an ingredient in an approved weight loss drug, but it's available only by prescription and must be used under the supervision of a physician. FDA tests have shown that people taking the counterfeit Alli in the dose specified on the package may be receiving several times the usual daily dose of sibutramine.
AR: People taking Alli should check to be sure they don't have the counterfeit version. Here are some things to look for:
• The counterfeit has a missing lot number on the outer cardboard packaging;
• The counterfeit has an expiration date that includes a month, day and year - the real Alli only has a month and year;
• The foil safety seal on the mouth of the counterfeit bottle has no writing - the seal on the real Alli says "Sealed for your protection";
• The counterfeit capsules contain a white powder - the real capsules contain small white pellets;
• The counterfeit version is packaged in a plastic bottle that has a slightly taller and wider cap than the real Alli, with coarser ribbing.
MB: People who think they may have the counterfeit product should stop using it immediately and contact FDA's Office of Criminal Investigations at 1-800-551-3989. Anyone having side effects such as nausea, insomnia and an unusually fast or irregular heartbeat, should contact their healthcare professional. And that's especially important for people with a history of heart disease.

"Sealed for your protection"	absorption of fats from the diet
approved by FDA	approved weight loss drug
coarser ribbing	counterfeit
counterfeit capsule	counterfeit product
daily dose	dose specified on the package
especially important	expiration date
fatal	FDA
foil safety seal	genuine version
healthcare	healthcare professional
heart disease	insomnia
lot number	missing lot number
nausea	numb
Office of Criminal Investigations	only by prescription
orlistat	outer cardboard packaging
over-the-counter	over-the-counter use
physician	plastic bottle
potentially dangerous	potentially fatal
potentially fatal side effect	several times the usual daily dose
sibutramine	slightly taller and wider cap
small white pellet	sold on the internet
stimulant drug	the public
To date	under the supervision
under the supervision of a physician	unusually fast or irregular heartbeat
weight loss	weight-loss drug

标题
Warning on Counterfeit Alli (FDA)

视频介绍
FDA Patient Safety News - March, 2010 - Show #96
FDA is warning the public about a potentially dangerous counterfeit version of the weight-loss drug Alli (orlistat).

Speaker #1: Anita Rayner (AR), Associate Director, Policy & Communications, U.S. Food and Drug Administration

Speaker #2: Mark Barnett (MB), Assistant Director, Education & Communication, U.S. Food and Drug Administration